{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:25:56Z","timestamp":1785911156365,"version":"3.56.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Prostate Cancer"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.3816\/cgc.2004.n.011","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:07:11Z","timestamp":1221095231000},"page":"38-42","source":"Crossref","is-referenced-by-count":10,"title":["Assessing a Prostate Cancer Brachytherapy Technique Using Early Patient-Reported Symptoms: A Potential Early Indicator for Technology Assessment?"],"prefix":"10.3816","volume":"3","author":[{"given":"Pearl H.","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony V.","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith B.","family":"Manola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya P.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Talcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CGC.2004.n.011_bib1","series-title":"Cancer Facts & Figures 2004","author":"American Cancer Society","year":"2004"},{"key":"10.3816\/CGC.2004.n.011_bib2","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/1097-0142(19950401)75:7+<2000::AID-CNCR2820751641>3.0.CO;2-4","article-title":"Health-related quality of life after treatment for localized prostate cancer","volume":"75","author":"Litwin","year":"1995","journal-title":"Cancer"},{"key":"10.3816\/CGC.2004.n.011_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1200\/JCO.1998.16.1.275","article-title":"Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study","volume":"16","author":"Talcott","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CGC.2004.n.011_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1200\/JCO.1996.14.1.304","article-title":"Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out","volume":"14","author":"D'Amico","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.3816\/CGC.2004.n.011_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1096-9098(199709)66:1<65::AID-JSO13>3.0.CO;2-N","article-title":"Interstitial implantation techniques in prostate cancer","volume":"66","author":"Sylvester","year":"1997","journal-title":"J Surg Oncol"},{"key":"10.3816\/CGC.2004.n.011_bib6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0360-3016(95)02050-0","article-title":"Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer","volume":"35","author":"Stock","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3816\/CGC.2004.n.011_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1053-4296(05)80121-3","article-title":"Brachytherapy and organ preservation in the management of carcinoma of the prostate","volume":"3","author":"Blasko","year":"1993","journal-title":"Sem Rad Oncol"},{"key":"10.3816\/CGC.2004.n.011_bib8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1200\/JCO.1996.14.2.449","article-title":"Tumor control and morbidity following transperineal iodine 125 implantation for stage T1\/T2 prostatic carcinoma","volume":"14","author":"Wallner","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.3816\/CGC.2004.n.011_bib9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1200\/JCO.1999.17.2.517","article-title":"Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer","volume":"17","author":"Zelefsky","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CGC.2004.n.011_bib10","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-5347(05)65970-8","article-title":"Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated","volume":"166","author":"Talcott","year":"2001","journal-title":"J Urol"},{"key":"10.3816\/CGC.2004.n.011_bib11","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2003.01.199","article-title":"Time course and predictors of symptoms after primary prostate cancer therapy","volume":"21","author":"Talcott","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3816\/CGC.2004.n.011_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0360-3016(94)00599-G","article-title":"Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy","volume":"32","author":"Wallner","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3816\/CGC.2004.n.011_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0360-3016(98)00271-5","article-title":"Real-time magnetic resonance image-guided interstitial brachytherapy in the treatment of select patients with clinically localized prostate cancer","volume":"42","author":"D'Amico","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3816\/CGC.2004.n.011_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1520-6823(1998)6:2<90::AID-ROI4>3.0.CO;2-C","article-title":"Comparison of MRI- and CTbased post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy","volume":"6","author":"Prete","year":"1998","journal-title":"Radiat Oncol Investig"},{"key":"10.3816\/CGC.2004.n.011_bib15","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00005650-200110000-00009","article-title":"Symptom indexes to assess outcomes of treatment for early prostate cancer","volume":"39","author":"Clark","year":"2001","journal-title":"Med Care"},{"key":"10.3816\/CGC.2004.n.011_bib16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ijc.1037","article-title":"Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications","volume":"96","author":"Han","year":"2001","journal-title":"Int J Cancer"},{"key":"10.3816\/CGC.2004.n.011_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/pros.2990040506","article-title":"Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations","volume":"4","author":"Walsh","year":"1983","journal-title":"Prostate"},{"key":"10.3816\/CGC.2004.n.011_bib18","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0022-5347(05)65870-3","article-title":"Quality of life after treatment for localized prostate cancer: differences based on treatment modality","volume":"166","author":"Davis","year":"2001","journal-title":"J Urol"},{"key":"10.3816\/CGC.2004.n.011_bib19","first-page":"147","article-title":"A prospective analysis of patient-reported quality of life after prostate brachytherapy","volume":"18","author":"Lee","year":"2000","journal-title":"Semin Urol Oncol"},{"key":"10.3816\/CGC.2004.n.011_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.20.2.557","article-title":"Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer","volume":"20","author":"Wei","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.3816\/CGC.2004.n.011_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00130404-200201000-00012","article-title":"I-125 versus Pd-103 for low-risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial","volume":"8","author":"Wallner","year":"2002","journal-title":"Cancer J"}],"container-title":["Clinical Prostate Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1540035211700592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1540035211700592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T23:23:14Z","timestamp":1545780194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1540035211700592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1540035211700592"],"URL":"https:\/\/doi.org\/10.3816\/cgc.2004.n.011","relation":{},"ISSN":["1540-0352"],"issn-type":[{"value":"1540-0352","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}